ChargePoint Details Executive Compensation, Missed Bonuses, and Ongoing Dilution in Annual Proxy
CHPT sits 76% above its 52-week low of $4.44.
Summary
ChargePoint's latest proxy statement outlines that executives missed FY26 bonuses due to unmet performance targets and details substantial ongoing share dilution from equity plans, while also introducing more performance-based compensation.
Key Events · Corporate Governance and Compliance · CHPT
-
No Executive Bonuses for FY26
Named executive officers did not receive annual bonuses for fiscal year 2026 as the company failed to achieve its adjusted EBITDA performance targets.
-
Increased Performance-Based Equity
A significant portion of executive equity awards for FY26 (75% for CEO, 33% for other NEOs) are now Performance-Based Restricted Stock Units (PRSUs) tied to FY27 adjusted EBITDA targets.
-
Ongoing Share Dilution
Equity compensation plans include automatic annual increases, with the 2021 Equity Incentive Plan increasing by 5% of outstanding shares each March 1st, representing substantial potential future dilution.
-
Board Composition Change
Director Elaine L. Chao was not nominated for re-election, which will reduce the Board of Directors from 12 to 11 members after the annual meeting.
Analysis · CHPT · Manufacturing
This definitive proxy statement reveals that ChargePoint's executive officers received no bonuses for fiscal year 2026 due to the company failing to meet its adjusted EBITDA targets, highlighting recent performance challenges. The filing also details significant ongoing potential dilution from equity incentive plans, which automatically increase by 5% of outstanding shares annually, alongside other share reserves. While the compensation structure is shifting towards more performance-based equity, the overall picture points to a company grappling with operational goals and shareholder value.
At the time of this filing, CHPT was trading at $7.83 on NYSE in the Manufacturing sector, with a market capitalization of approximately $190.4M. The 52-week trading range was $4.44 to $17.78. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.